Literature DB >> 22402946

Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathy.

A Bierhaus1, P P Nawroth.   

Abstract

A number of studies have addressed diabetic neuropathy (DN) in transgenic and knock out mouse models to unravel the molecular mechanisms underlying metabolic pain and loss of pain perception. However, it is difficult to compare these studies with each other or even with human DN due to experimental differences including the type of diabetes, the background strain of the respective mouse model, the methods of diabetes induction and the duration of diabetes, animal age and gender. To receive useful information for DN from genetically modified mice, it is therefore mandatory to first define the appropriate model and - if necessary - to backcross transgenic strains into the respective background to allow a reliable (and at least in part translatable to human DN) interpretation of the results. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22402946     DOI: 10.1055/s-0032-1304567

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

Review 1.  Institutional animal care and use committee considerations for animal models of peripheral neuropathy.

Authors:  Thea Brabb; Larry Carbone; Jessica Snyder; Nona Phillips
Journal:  ILAR J       Date:  2014

2.  Towards further defining the proteome of mouse saliva.

Authors:  Anne A Blanchard; Peyman Ezzati; Dmitry Shamshurin; Andreea C Nistor; Etienne Leygue; John A Wilkins; Yvonne Myal
Journal:  Proteome Sci       Date:  2015-02-25       Impact factor: 2.480

3.  Beneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice.

Authors:  Anne Gomez-Brouchet; Nelly Blaes; Lionel Mouledous; Olivier Fourcade; Ivan Tack; Bernard Francès; Jean-Pierre Girolami; Vincent Minville
Journal:  J Transl Med       Date:  2015-07-02       Impact factor: 5.531

Review 4.  microRNAs in nociceptive circuits as predictors of future clinical applications.

Authors:  Michaela Kress; Alexander Hüttenhofer; Marc Landry; Rohini Kuner; Alexandre Favereaux; David Greenberg; Josef Bednarik; Paul Heppenstall; Florian Kronenberg; Marzia Malcangio; Heike Rittner; Nurcan Uçeyler; Zlatko Trajanoski; Peter Mouritzen; Frank Birklein; Claudia Sommer; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2013-10-17       Impact factor: 5.639

5.  Role of MicroRNA in Visceral Pain.

Authors:  Jian Zhang; Banani Banerjee
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

6.  Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.

Authors:  Karen Alejandra Méndez-Lara; David Santos; Núria Farré; Sheila Ruiz-Nogales; Sergi Leánez; José Luis Sánchez-Quesada; Edgar Zapico; Enrique Lerma; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Jesús María Martín-Campos; Josep Julve; Olga Pol
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.